Repeated supratherapeutic dosing of strontium ranelate over 15 days does not prolong QT(c) interval in healthy volunteers

AIMS: The study was performed to assess the safety of strontium ranelate in accordance with the ICH, E14 guidelines for QT/QT(c) studies. Its primary objective was to compare supratherapeutic repeated dosing of strontium ranelate (4 g day(−1) for 15 days) with placebo on the largest time-matched mea...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Taubel, Jorg, Naseem, Asif, Wang, Duolao, Arezina, Radivoj, Lorch, Ulrike, Camm, A. John
Formato: Artigo
Idioma:Inglês
Publicado: Blackwell Publishing Ltd 2012
Assuntos:
Clinical Trials
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3630749/
https://ncbi.nlm.nih.gov/pubmed/22283848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2012.04190.x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares